Kilitch Drugs(India) Quarterly Results

Charts

YoY Net Sales (Quarterly)

Operating Margin

EPS Growth

POSITIVES

Strong revenue growth in the latest quarter, reaching ₹47.48 crore, up from ₹41.20 crore in Q3 2023.
Operating profit margin improved significantly in Q4 2023, indicating better cost management.
Net profit rebounded to ₹8.61 crore in Q4 2023, showcasing a recovery from prior losses.

NEGATIVES

Expenses increased sharply in Q4 2023, rising to ₹42.29 crore, impacting profitability.
Operating profit margin dropped to 10.92% in Q4 2023 from 15.28% in Q3 2023, signaling rising costs.
Net profit declined to ₹1.74 crore in Q3 2023, highlighting volatility in earnings.

Field	Mar 23	Jun 23	Sep 23	Dec 23	Mar 24	Jun 24	Sep 24	Dec 24	Mar 25	Jun 25
Revenue	45.48	36.56	41.20	31.79	44.82	33.45	47.48	56.17	61.23	43.14
Expenses	39.26	30.38	32.58	29.51	37.74	31.79	41.38	47.43	46.63	39.88
Operating Profit	6.21	6.18	8.62	2.28	7.08	1.66	6.09	8.74	14.59	3.26
Other Income	1.02	0.56	0.49	2.96	0.47	2.57	5.16	1.73	1.70	2.56
Interest	1.21	1.50	1.51	1.60	1.32	1.73	0.31	1.40	1.60	1.53
Depreciation	0.91	0.79	0.82	0.82	0.93	0.85	0.60	0.81	0.85	0.84
Profit Before Tax	5.11	4.45	6.78	2.82	5.30	1.65	10.35	8.25	13.84	3.45
Tax	2.21	1.39	1.69	1.08	1.62	1.54	1.73	2.64	3.62	1.19
Net Profit	2.90	3.06	5.09	1.74	3.68	0.11	8.61	5.62	10.22	2.26
Eps in Rs	2.29	2.15	2.93	1.85	2.24	0.83	5.36	3.71	6.47	1.88